Biotech Values

[biopearl]

Thanks Peter, I asked specifically since the cancer stem cell hypothesis seems so compelling yet Geron has floundered with company sponsored trials testing imetelstat, a telomerase inhibitor. Recently an NCI sponsored study was posted and clinicaltrials.gov which is a phase II trial in pediatric brain tumors. I just wondered if more interest in the drug was reflected in this approach or whether it was simply a dollars and cents decision by the company to not fund where they don't have to. I suppose if there were no potential for the drug the various high power academic institutions participating would be less interested unless the compensation provided for doing the study trumped their pure interest in contributing to the general body of knowledge. bp